<DOC>
	<DOCNO>NCT00310323</DOCNO>
	<brief_summary>The purpose research study determine effect chronic nighttime low oxygen saturation select body system ( liver ) break drug child obstructive sleep apnea syndrome ( OSAS ) .</brief_summary>
	<brief_title>Hepatic Drug Biotransformation Children With Obstructive Sleep Apnea</brief_title>
	<detailed_description>The purpose study determine effect chronic intermittent nocturnal hypoxia select hepatic drug-metabolizing enzyme system child OSAS . The specific aim evaluate activity cytochrome P450 ( CYP ) 1A2 , N-acetyltransferase-2 ( NAT-2 ) , xanthine oxidase ( XO ) CYP2D6 child OSAS determine effect OSAS treatment activity enzyme system .</detailed_description>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<mesh_term>Dextromethorphan</mesh_term>
	<mesh_term>Caffeine</mesh_term>
	<criteria>Children age 4 16 year suspect uncomplicated OSAS Children complicate OSAS ( craniofacial abnormality , neuromuscular disorder ) Children receive medication know induce inhibit hepatic CYP1A2 , NAT2 , XO , CYP2D6 CYP3A4 activity Children expose second hand smoke great 8 hour per day . Children hypersensitivity caffeine dextromethorphan Children receive corticosteroid thyroid hormone</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>sleep apnea</keyword>
	<keyword>phenotyping</keyword>
	<keyword>cytochrome P450</keyword>
	<keyword>drug metabolism</keyword>
	<keyword>child</keyword>
</DOC>